Stat 5B, activated by insulin in a Jak-independent fashion, plays a role in Glucokinase gene transcription

Endocrinology

Volumn 141, Issue 6, 2000, Pages 1977-1988

  Sawka Verhelle, Dominique ^a   Tartare Deckert, Sophie ^a   Decaux, Jean François ^b   Girard, Jean ^b   Van Obberghen, Emmanuel ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; CELL SURFACE RECEPTOR; CYTOKINE; GLUCOKINASE; GROWTH FACTOR; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C; STAT PROTEIN; STAT5B PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPORTER GENE; TRANSCRIPTION INITIATION;

EID: 0034458143     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.6.7496     Document Type: Article

References (67)

1. Tyk 2 prototype of a novel class of non-receptor tyrosine kinase genes
2. Jak2, a third member of the jak family of the protein tyrosine kinase
3. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction
4. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase
5. Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells
6. Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription
7. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors
8. STATs: Signal transducers and activators of transcription
9. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
10. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response
11. Cloning and expression of Stat 5 and an additional homologue (Stat 5B) involved in prolactin signal transduction in mouse mammary tissue
12. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity
13. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs
14. Thrombopoietin activates a STAT5-like factor in hematopoietic cells
15. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response
16. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor
17. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways
18. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
19. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-X(L) induction
20. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line
21. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation
22. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid
23. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2
24. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
25. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor
26. Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor
27. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins
28. Stat5 is a physiological substrate of the insulin receptor
29. Identification of Stat 5B as a substrate of the insulin receptor
30. Signalling through the insulin receptor and the insulin-like growth factor-I receptor
31. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins
32. The IRS-signalling system: A network of docking proteins that mediate insulin action
33. Luciferase reporter gene vectors for analysis of promoters and enhancers
34. Cloning and characterization of the mouse glucokinase gene locus and identification of distal liver-specific DNase I hypersensitive sites
35. Human glucokinase gene: Isolation, structural characterization, and identification of a microsatellite repeat polymorphism
36. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor
37. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
38. Activation of receptor-associated tyrosine kinase JAK2 by prolactin
39. Association of JAK2 and Stat 5 with erythropoietin receptors
40. Kinase-negative mutants of JAK1 can sustain interferon-gamma-reducible gene expression but not an antiviral state
41. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses
42. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway
43. Regulation of gene expression by insulin
44. Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats
45. Rat glucokinase gene: Structure and regulation by insulin
46. Involvement of Janus kinases in the insulin signaling pathway
47. Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor
48. Insulin induces tyrosine phosphorylation of JAK2 in insulin-sensitive tissues of the intact rat
49. Differential expression and regulation of the glucokinase gene in liver and islets of langerhans
50. An alternate promoter in the glucokinase gene is active in the pancreatic beta cell
51. Glucokinase as pancreatic beta cell glucose sensor and diabetes gene
52. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut
53. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system
54. Insulin signalling and regulation of glucokinase gene expression in cultured hepatocytes
55. Regulatory effects of glucose on the catalytic activity and cellular content of glucokinase in the pancreatic beta cell. Study using cultured rat islets
56. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes
57. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose
58. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes
59. SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I
60. Regulation of the sheep beta-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-gamma activation site-related element
61. Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice
62. Isolation and structural analysis of the mouse beta-casein gene
63. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells
64. Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1
65. Cloning of human Stat 5B
66. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain
67. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases